ArticleQuantitative imaging in medicine and surgery2026
Performance and incremental value of preoperative multimodal imaging and perioperative clinical characteristics in predicting postoperative major adverse events in type A aortic dissection.
Article in Quantitative imaging in medicine and surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Postoperative major adverse events (MAEs) can occur after surgical repair of acute Stanford type A aortic dissection (ATAAD), and conventional clinical assessment may not fully capture the prognostic information provided by preoperative multimodal imaging. This study aimed to develop and externally validate a staged risk prediction model for postoperative MAEs and to evaluate the incremental value of preoperative multimodal imaging relative to conventional clinical and laboratory assessment in the prediction of MAEs. Methods: In this retrospective, two-center cohort study, patients with surgically treated ATAAD were screened between April 2016 and April 2026. After application of predefined exclusion criteria, 1,960 patients were included, comprising a development cohort from Center I (n=1,498) and an external validation cohort from Center II (n=462). The development cohort was further randomly divided into a training set (n=1,048) and an internal validation set (n=450). Preoperative multimodal imaging and perioperative clinical data were collected, including computed tomography angiography (CTA), transthoracic/transesophageal echocardiography (TTE/TEE), admission laboratory indices, disease-severity indicators, and surgery-related variables. Candidate predictors were screened via least absolute shrinkage and selection operator (LASSO) regression and multivariable logistic regression. Five progressively expanded models were constructed to assess the incremental value of Penn classification, echocardiography, CTA, and intraoperative variables. Model performance was evaluated via receiver operating characteristic analysis, calibration curves, decision curve analysis (DCA), net reclassification improvement (NRI), and integrated discrimination improvement (IDI). Results: In the development cohort, postoperative MAEs occurred in 375 patients and did not occur in 1,123 patients. LASSO-based multivariable analysis identified age, lactate level, neutrophil-to-lymphocyte ratio (NLR), Penn classification, severe true lumen compression, mesenteric artery involvement, and cardiopulmonary bypass (CPB) time as the core predictors for incorporation into the final nomogram. Model discrimination improved progressively with staged expansion. In the training set, the areas under the curve of models 1-5 were 0.725, 0.768, 0.782, 0.852, and 0.868, respectively; in the internal validation set, they were 0.718, 0.755, 0.776, 0.841, and 0.858; and in the external validation cohort, they were 0.705, 0.742, 0.765, 0.832, and 0.848, respectively. The largest incremental gain was observed after addition of multimodal CTA variables. The final nomogram showed good calibration and favorable clinical utility in both the training and external validation cohorts. Risk stratification in the development cohort demonstrated a marked stepwise increase in observed MAE incidence from 3.7% in the low-risk group to 27.9% in the intermediate-risk group and 74.2% in the high-risk group (P for trend <0.001). Conclusions: A staged prediction model integrating preoperative multimodal imaging and perioperative clinical characteristics provided effective risk stratification for postoperative MAEs among patients with ATAAD. Preoperative CTA contributed the greatest incremental improvement beyond baseline clinical assessment, and the final nomogram demonstrated good discrimination, calibration, and clinical utility. This multimodal framework may support more precise perioperative risk assessment and individualized management for patients with surgically treated ATAAD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.